March 30, 2025 - 15:10

In a significant shakeup within the nation’s health agency, the FDA's leading vaccine official, Dr. Peter Marks, has resigned amid rising tensions. Dr. Marks expressed concerns over Health Secretary Robert F. Kennedy Jr.'s alleged demand for "subservient confirmation" of what he described as misinformation and lies. This resignation comes on the heels of a startling announcement from the Department of Health and Human Services (HHS), which revealed plans to lay off approximately 10,000 workers.
The implications of these developments are profound, as they could hinder the agency's ability to respond effectively to public health challenges. Experts warn that such drastic cuts may lead to a decrease in oversight and support for vital health initiatives, potentially jeopardizing the safety and efficacy of vaccines and other critical health programs. Former HHS leaders have voiced their concerns about the long-term effects on public health infrastructure, emphasizing the need for a stable and informed leadership to navigate ongoing health crises.
October 21, 2026 - 20:59
Sea Buckthorn and Respiratory Health: What Pharmacists Need to KnowSea buckthorn is a commonly used herbal for respiratory health, and US pharmacists are knowledgeable in educating patients on herbals, especially during the cold season. Sea buckthorn, known...
October 21, 2026 - 05:08
How You Drink Your Tea May Affect Heart Health, Study FindsThe way you prepare and drink your tea could influence your cardiovascular health, according to a new study. Researchers found that tea itself offers meaningful benefits for the heart, but those...
October 20, 2026 - 23:59
Maryland Expands Reproductive Health Training Program With State FundingThe University of Maryland is broadening a reproductive health initiative with more than $16 million in state grant funds spread across five years. The investment builds on earlier work that has...
October 20, 2026 - 13:46
GLP-1 Drugs Tied to Better Kidney Outcomes in Bipolar Disorder PatientsResearchers have found that GLP-1 receptor agonists, a class of medications commonly prescribed for diabetes and weight management, may offer significant protection for kidney health in adults...